High Lp(a) Linked to ASCVD Risk Even When LDL Cholesterol Is Low
While statins can reduce LDL levels and ASCVD events, high Lp(a) poses an independent risk that will need attention, too.
Related Articles
One machine learning question every day – bnomial
Daily multi-choice machine learning, data science, and artificial intelligence questions.
AHA24
Download the mobile program today to easily access event session s, speakers, exhibitors, and organizer messages. Use the native app to personalize your schedule, take…
JACC Journals at AHA | JACC | AHA 2024
Join Harlan Krumholz, editor-in-chief of JACC, as he highlights groundbreaking cardiovascular science presented at this year’s American Heart Association Sci…
Diabetes and obesity: leveraging heterogeneity for precision medicine
Abstract. The increasing prevalence of diabetes, obesity, and their cardiometabolic sequelae present major global health challenges and highlight shortfall
Advancing the Cardiovascular Care of the Oncology Patient (In-Person) – American College of Cardiology
Advancing the Cardiovascular Care of the Oncology Patient is an interdisciplinary and interspecialty course to provide clinicians and researchers with the tools needed to improve…
Tirzepatide for Obesity Treatment and Diabetes Prevention | NEJM
Obesity is chronic disease and causal precursor to myriad other conditions, including type 2 diabetes. In an earlier analysis of the SURMOUNT-1 trial, tirzepatide was…
Abstract 4122620: Triglyceride Levels Associate With Cardiovascular Risk Across the Full Range but Not Among Individuals With Mild-to-Moderate Hypertriglyceridemia | Circulation
Background: Guidelines focus on individuals with triglyceride levels of 200 to 499 mg/dL (2.3 and 5.6 mmol/L), a group for whom triglyceride-lowering therapy does not…
AHA24
Download the mobile program today to easily access event session s, speakers, exhibitors, and organizer messages. Use the native app to personalize your schedule, take…
Rahul Rajkumar: Intensive Home-Based Care for High-Need Patients
Howie and Harlan are joined by Rahul Rajkumar, founder and CEO of Accompany Health, which provides a team of providers for patients who are on…
[99mTc]-PentixaTec SPECT/CT for Imaging of Chemokine Receptor 4 Expression After Myocardial Infarction | Circulation: Cardiovascular Imaging
BACKGROUND: Accumulation of CXCR4 (C-X-C motif chemokine receptor 4)–positive immune cells after acute myocardial infarction (AMI) can be visualized by positron emission tomography. For a…
